Altasciences Further Expands its Footprint with Algorithme Pharma USA
Altasciences is pleased to announce the opening of Algorithme Pharma USA, further expanding the Company’s North American footprint and ability to provide comprehensive Bioequivalence and Phase I/IIa clinical drug development capabilities in the United States.
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.